Effect of a Digital Health Education Program on Quality of Life in Women With Polycystic Ovary Syndrome
2 other identifiers
interventional
70
1 country
1
Brief Summary
This single-blind randomized controlled trial evaluated the effectiveness of a digital health education program delivered through WhatsApp in improving the quality of life of women with polycystic ovary syndrome (PCOS). Seventy women diagnosed with PCOS were enrolled from selected gynecology clinics in Imo State, Nigeria, and allocated to either an intervention group or a routine care control group. The intervention consisted of a four-week digital education program including 30 evidence-based educational messages. Quality of life was measured using the Polycystic Ovary Syndrome Quality of Life Questionnaire (PCOSQ) at baseline and one month after completion of the intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 25, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 24, 2026
CompletedFirst Submitted
Initial submission to the registry
June 29, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
CompletedFirst Posted
Study publicly available on registry
July 6, 2026
CompletedJuly 6, 2026
June 1, 2026
2 months
June 29, 2026
June 29, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Quality of Life
The primary outcome measure evaluates changes in the quality of life of women diagnosed with polycystic ovary syndrome (PCOS) following the digital health education program. Quality of life is assessed using the Polycystic Ovary Syndrome Quality of Life Questionnaire (PCOSQ), a validated 26-item disease-specific instrument that measures emotional disturbances, body hair concerns, weight concerns, infertility problems, and menstrual problems. Higher scores indicate better quality of life.
Baseline (before the intervention) and 1 month after completion of the intervention.
Study Arms (2)
Digital Health Education Program
EXPERIMENTALParticipants in this group received a four-week digital health education program delivered through WhatsApp. The intervention provided structured educational messages designed to improve knowledge, self-management, and quality of life among women with polycystic ovary syndrome (PCOS).
Routine Care
ACTIVE COMPARATORParticipants in this group received routine care and standard health information provided by the participating women's health wards and gynecology clinics. No digital health education program was provided during the study period.
Interventions
Participants received a four-week digital health education program delivered through WhatsApp. The intervention consisted of 30 structured educational messages covering polycystic ovary syndrome (PCOS), lifestyle modification, nutrition, physical activity, stress management, fertility, and prevention of long-term complications. Participants were encouraged to ask questions through WhatsApp, and researchers provided clarification when needed.
Participants received routine care and standard health information provided by the participating women's health wards and gynecology clinics. They did not receive the digital health education program during the study period. After completion of data collection, the educational materials were provided to participants in the control group.
Eligibility Criteria
You may qualify if:
- Women diagnosed with polycystic ovary syndrome
- Women aged 18-45 years
- Women attending the selected women's health wards and gynecology clinics during the study period
- Willingness to participate and provide written informed consent
You may not qualify if:
- Withdrawal of consent at any stage of the study
- Failure to complete either the pre-test or post-test assessments
- Incomplete participation in the educational intervention program
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pouran Varvani Farahani
Nicosia, Haspolat, Cyprus
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pouran Varvani Farahani, PhD
PhD in Pediatric Nursing, Department of Nursing, Faculty of Health Science, Cyprus International University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- To reduce bias, the outcome assessor and the statistician responsible for data analysis were blinded to group assignments.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD in Pediatric Nursing, Department of Nursing, Faculty of Health Science, Cyprus International University
Study Record Dates
First Submitted
June 29, 2026
First Posted
July 6, 2026
Study Start
April 25, 2026
Primary Completion
June 24, 2026
Study Completion
June 30, 2026
Last Updated
July 6, 2026
Record last verified: 2026-06
Data Sharing
- IPD Sharing
- Will not share
There is no plan to make IPD available to other researchers